Phase 2 Study of Epacadostat (INCB024360) With Pembrolizumab (MK3475) in Metastatic or Unresectable Gastroesophageal Junction and Gastric Adenocarcinoma Requiring Paired Biopsies
Latest Information Update: 29 Jan 2024
At a glance
- Drugs Epacadostat (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 05 Jun 2020 Status changed from recruiting to completed.
- 18 Jan 2018 Trial design of the study presented at the 2018 Gastrointestinal Cancers Symposium.
- 19 Sep 2017 Planned End Date changed from 1 Jun 2019 to 1 Sep 2019.